ADJUVANT TARGET DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES.

DEFINITIVE CONTRACT won by INTEGRAL MOLECULAR INC · work in PHILADELPHIA, PA
$600,000
RecipientINTEGRAL MOLECULAR INC UEI DY9KSWE8EJB8
Award ID75N93022C00032
Award amount$600,000
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN12
Start dateJun 30, 2022
End dateJun 29, 2024
Place of performancePHILADELPHIA, PA
Record updatedJan 3, 2025

View the official award record

More awards won by INTEGRAL MOLECULAR INC

B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION
Department of Health and Human Services · $6,450,277 · Sep 16, 2019
TO DISCOVER AND CHARACTERIZE B CELL EPITOPES AGAINST THE VIRAL PATHOGENS RVFV, CCHFV, AND EV-D68.
Department of Health and Human Services · $3,291,808 · Sep 16, 2024
ANTIBODY REAGENTS FOR IMMUNOLOGIC ANALYSIS OF UNDER-REPRESENTED MAMMALIAN MODELS
Department of Health and Human Services · $1,500,000 · Jun 1, 2025
SBIR TOPIC 118: REAGENTS FOR IMMUNOLOGIC ANALYSIS OF NON-MAMMALIAN AND UNDERREPRESENTED MAMMALIAN MODELS.
Department of Health and Human Services · $600,000 · Sep 1, 2023

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids